Bottom line
Is RSDGX a good fund? The bottom line
RSDGX is the Class A share class of Victory RS Select Growth Fund, a managed large growth mutual fund from Victory Capital.
Annual fees run 1.4% — about $140 a year on every $10,000 invested, more expensive than 85% of large growth funds we track.
It returned +1.1% over one year, +1.4% a year over five years, +8.1% a year over ten (as of Dec 31, 2025, per its prospectus).
With $91.2 million in net assets and 66 holdings, its largest position is Guardant Health, Inc. (3.7%) and the top 10 make up 27.5% of the portfolio.
This share class carries a front-end sales charge of up to 5.75%; a no-load class or ETF alternative can avoid it.
What to watch
- Expensive for its category (1.4%)
- 5-year return in the bottom quarter of its category
- Front-end sales load up to 5.75%
- 12b-1 marketing fee of 0.25% a year
Updated Nov 19, 2026
What RSDGX invests in
The Victory RS Select Growth Fund (the Fund) seeks to provide long-term capital growth.
The Adviser pursues the Funds investment objective by investing, under normal circumstances, in a portfolio of small- and mid-capitalization growth-oriented companies. The Fund typically invests in equity securities of U.S. companies but may also invest any portion of its assets in foreign securities, including depositary receipts such as American Depositary Receipts (ADRs) and Global Depositary Receipts (GDRs). The Fund principally invests in equity securities of companies with market capitalizations (at the time of purchase) less than $8 billion or 120% of the market capitalization of the largest company included in the Russell 2500 Index (the Index) (currently, approximately $112.5 billion, based on the size of the largest company in the Index on March 31, 2026), whichever is greater. The size of companies in the Index changes with market conditions and the composition of the Index.…
From the fund's prospectus (filed Jun 17, 2026).
RSDGX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| RSDGX | +1.1% | +1.4% | +8.1% |
| Large Growth median | +15.2% | +11.0% | +14.2% |
Source: Fund prospectus, as of Dec 31, 2025
What RSDGX costs
On a $10,000 investment, RSDGX's 1.4% expense ratio costs about $140 a year. The prospectus estimates $2,283 in total costs over 10 years (assuming 5% annual returns). The median large growth fund charges 0.87%.
RSDGX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Guardant Health, Inc. | 3.66% |
| 2 | Macom Technology Solutions Holdings, Inc. | 3.47% |
| 3 | Woodward, Inc. | 3.01% |
| 4 | Mercury Systems, Inc. | 2.92% |
| 5 | Comfort Systems USA, Inc. | 2.52% |
| 6 | Revolution Medicines, Inc. | 2.51% |
| 7 | Firstcash Holdings, Inc. | 2.48% |
| 8 | Sterling Infrastructure, Inc. | 2.35% |
| 9 | Onto Innovation Inc. | 2.33% |
| 10 | Semtech Corporation | 2.29% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 27.5% of the fund. See all top 25 holdings and asset mix →